ALX Oncology Holdings Statistics
Total Valuation
ALXO has a market cap or net worth of $320.42 million. The enterprise value is $172.68 million.
Market Cap | 320.42M |
Enterprise Value | 172.68M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ALXO has 52.10 million shares outstanding. The number of shares has increased by 22.66% in one year.
Shares Outstanding | 52.10M |
Shares Change (YoY) | +22.66% |
Shares Change (QoQ) | +2.16% |
Owned by Insiders (%) | 2.03% |
Owned by Institutions (%) | 93.98% |
Float | 21.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.95 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.06.
Current Ratio | 5.21 |
Quick Ratio | n/a |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -102.55 |
Financial Efficiency
Return on equity (ROE) is -90.40% and return on invested capital (ROIC) is -101.12%.
Return on Equity (ROE) | -90.40% |
Return on Assets (ROA) | -72.20% |
Return on Capital (ROIC) | -101.12% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.31M |
Employee Count | 72 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.56% in the last 52 weeks. The beta is 1.06, so ALXO's price volatility has been similar to the market average.
Beta (5Y) | 1.06 |
52-Week Price Change | -13.56% |
50-Day Moving Average | 9.56 |
200-Day Moving Average | 11.59 |
Relative Strength Index (RSI) | 38.79 |
Average Volume (20 Days) | 1,131,802 |
Short Selling Information
The latest short interest is 5.51 million, so 10.58% of the outstanding shares have been sold short.
Short Interest | 5.51M |
Short Previous Month | 4.24M |
Short % of Shares Out | 10.58% |
Short % of Float | 25.82% |
Short Ratio (days to cover) | 4.75 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -175.84M |
Pretax Income | -166.20M |
Net Income | -166.20M |
EBITDA | -163.76M |
EBIT | -164.60M |
Earnings Per Share (EPS) | -$3.71 |
Balance Sheet
The company has $157.44 million in cash and $9.70 million in debt, giving a net cash position of $147.73 million or $2.84 per share.
Cash & Cash Equivalents | 157.44M |
Total Debt | 9.70M |
Net Cash | 147.73M |
Net Cash Per Share | $2.84 |
Equity (Book Value) | 164.20M |
Book Value Per Share | 3.15 |
Working Capital | 135.64M |
Cash Flow
In the last 12 months, operating cash flow was -$140.47 million and capital expenditures -$732,000, giving a free cash flow of -$141.20 million.
Operating Cash Flow | -140.47M |
Capital Expenditures | -732,000 |
Free Cash Flow | -141.20M |
FCF Per Share | -$2.82 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALXO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.66% |
Shareholder Yield | -22.66% |
Earnings Yield | -51.87% |
FCF Yield | -44.07% |
Analyst Forecast
The average price target for ALXO is $20.50, which is 233.33% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.50 |
Price Target Difference | 233.33% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |